HUT64210A - Process for producing system for releasing active agents in the large intestine - Google Patents

Process for producing system for releasing active agents in the large intestine

Info

Publication number
HUT64210A
HUT64210A HU9203451A HU345192A HUT64210A HU T64210 A HUT64210 A HU T64210A HU 9203451 A HU9203451 A HU 9203451A HU 345192 A HU345192 A HU 345192A HU T64210 A HUT64210 A HU T64210A
Authority
HU
Hungary
Prior art keywords
matrix
colon
drug
active agents
large intestine
Prior art date
Application number
HU9203451A
Other languages
English (en)
Other versions
HU9203451D0 (en
HU210497B (en
Inventor
Amnon Sinto
Abraham Rubinstein
Original Assignee
Perio Prod Ltd
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24065163&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUT64210(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Perio Prod Ltd, Yissum Res Dev Co filed Critical Perio Prod Ltd
Publication of HU9203451D0 publication Critical patent/HU9203451D0/hu
Publication of HUT64210A publication Critical patent/HUT64210A/hu
Publication of HU210497B publication Critical patent/HU210497B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Surgical Instruments (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
HU9203451A 1990-05-04 1991-05-02 Process for production of modified pectin HU210497B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51871490A 1990-05-04 1990-05-04

Publications (3)

Publication Number Publication Date
HU9203451D0 HU9203451D0 (en) 1993-05-28
HUT64210A true HUT64210A (en) 1993-12-28
HU210497B HU210497B (en) 1995-04-28

Family

ID=24065163

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9203451A HU210497B (en) 1990-05-04 1991-05-02 Process for production of modified pectin

Country Status (17)

Country Link
EP (1) EP0527942B1 (hu)
JP (1) JPH05508631A (hu)
KR (1) KR100194161B1 (hu)
AT (1) ATE185267T1 (hu)
AU (1) AU660147B2 (hu)
BR (1) BR9106419A (hu)
CA (1) CA2082156A1 (hu)
DE (2) DE69131688T2 (hu)
DK (1) DK0527942T3 (hu)
ES (1) ES2048133T3 (hu)
FI (1) FI924984L (hu)
GR (2) GR940300025T1 (hu)
HU (1) HU210497B (hu)
MC (1) MC2288A1 (hu)
NO (1) NO306096B1 (hu)
RU (1) RU2113221C1 (hu)
WO (1) WO1991016881A1 (hu)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4209160A1 (de) * 1992-03-20 1993-09-30 Bauer Kurt Heinz Prof Dr Vernetzte Polysaccharide, Verfahren zu ihrer Herstellung und ihre Verwendung
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
AU695906B2 (en) * 1993-11-17 1998-08-27 Commonwealth Scientific And Industrial Research Organisation Fatty acid delivery system
DE69429927T2 (de) * 1993-11-17 2002-11-07 The Commonwealth Scientific And Industrial Research Organization, Campbell Fettsäure-abgabesystem
DE4340057A1 (de) * 1993-11-24 1995-06-01 Falk Pharma Gmbh Budesonid-Arzneimittel zur Verbesserung der enteralen Flüssigkeitsresorption, insbesondere nach postoperativen Zuständen
DE69528583T2 (de) * 1994-04-22 2003-07-10 Yamanouchi Pharmaceutical Co., Ltd. Kolon-spezifisches arzneistofffreisetzungssystem
US5849327A (en) * 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
US5656294A (en) * 1995-06-07 1997-08-12 Cibus Pharmaceutical, Inc. Colonic delivery of drugs
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
ES2163000T3 (es) * 1996-01-16 2002-01-16 Advanced Polymer Systems Inc Suministro topico de farmacos al tracto gastrointestinal inferior.
FR2752843B1 (fr) * 1996-08-30 1998-10-16 Sod Conseils Rech Applic Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
WO1998026767A2 (en) * 1996-12-17 1998-06-25 Poli Industria Chimica S.P.A. Site-specific controlled release dosage formulation for mesalamine
US6229009B1 (en) 1997-08-29 2001-05-08 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Polycarboxylic based cross-linked copolymers
AU2484399A (en) * 1998-01-30 1999-08-16 Scios Inc. Controlled release delivery of peptide or protein
KR20000011247A (ko) * 1998-07-23 2000-02-25 김윤 다당류를이용한대장선택성약물전달조성물및약학제제
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.
IT1303735B1 (it) * 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
AU5108200A (en) 1999-06-09 2000-12-28 Mochida Pharmaceutical Co., Ltd. System for release in lower digestive tract
FR2799196B1 (fr) * 1999-10-04 2002-02-08 Sod Conseils Rech Applic Copolymeres reticules a base de copolymeres polycarboxyliques non reticules
RU2188000C1 (ru) * 2001-09-27 2002-08-27 Нестерук Владимир Викторович Лекарственное средство на основе тамоксифена
US20060110517A1 (en) * 2003-01-31 2006-05-25 Reinhold Carle Novel compositions comprising carotenoids
US7670624B2 (en) 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
ATE468846T1 (de) * 2004-03-26 2010-06-15 Lek Pharmaceuticals Magenresistente pharmazeutische dosierform mit n- (2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d- glutaminsäure (lk-423)
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
KR101122845B1 (ko) 2009-07-30 2012-03-21 부산대학교 산학협력단 경구용 염증성 장질환 치료제
EP2830599B1 (en) 2012-03-29 2018-08-15 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
CN110075130A (zh) 2013-03-14 2019-08-02 塞拉拜姆有限责任公司 益生生物和/或治疗剂的靶向胃肠道递送
WO2016114397A1 (ja) 2015-01-16 2016-07-21 生化学工業株式会社 コンドロイチン硫酸架橋体、並びにこれを含有する組成物、及び眼疾患処置剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7504049L (sv) * 1975-04-09 1976-10-10 Haessle Ab Colonpreparation
DE2717707C3 (de) * 1977-04-21 1979-11-22 Chephasaar Chemisch-Pharmazeutische Fabrik Gmbh, 6670 St Ingbert Karamellisierte Lactulose
US4668517A (en) * 1985-04-04 1987-05-26 Norwich Eaton Pharmaceuticals, Inc. Furazolidone dosage form
ZA881301B (en) * 1987-02-27 1989-10-25 Lilly Co Eli Sustained release matrix formulations
DK110188D0 (da) * 1988-03-02 1988-03-02 Claus Selch Larsen High molecular weight prodrug derivatives of antiinflammatory drugs
US4857331A (en) * 1988-03-31 1989-08-15 Warner-Lambert Company Sugarless pectin delivery system
IT1219942B (it) * 1988-05-13 1990-05-24 Fidia Farmaceutici Esteri polisaccaridici
DE4006521A1 (de) * 1990-03-02 1991-09-05 Bayer Ag Zuckerhaltige polymere zur umhuellung und einbettung von arzneistoffen

Also Published As

Publication number Publication date
BR9106419A (pt) 1993-05-04
FI924984A0 (fi) 1992-11-04
MC2288A1 (fr) 1993-07-14
JPH05508631A (ja) 1993-12-02
NO924227L (no) 1992-12-30
NO306096B1 (no) 1999-09-20
AU660147B2 (en) 1995-06-15
DE69131688T2 (de) 2000-05-25
ES2048133T1 (es) 1994-03-16
ATE185267T1 (de) 1999-10-15
DE527942T1 (de) 1994-03-03
WO1991016881A1 (en) 1991-11-14
AU8087791A (en) 1991-11-27
DE69131688D1 (de) 1999-11-11
GR940300025T1 (hu) 1994-05-31
EP0527942B1 (en) 1999-10-06
HU9203451D0 (en) 1993-05-28
KR100194161B1 (ko) 1999-06-15
FI924984A7 (fi) 1992-11-04
EP0527942A4 (en) 1993-10-13
EP0527942A1 (en) 1993-02-24
DK0527942T3 (da) 2000-03-27
ES2048133T3 (es) 2000-01-16
GR3031906T3 (en) 2000-02-29
HU210497B (en) 1995-04-28
RU2113221C1 (ru) 1998-06-20
FI924984L (fi) 1992-11-04
CA2082156A1 (en) 1991-11-05
NO924227D0 (no) 1992-11-03

Similar Documents

Publication Publication Date Title
HUT64210A (en) Process for producing system for releasing active agents in the large intestine
BR0013948A (pt) Prodroga, composição farmacêutica, e, método de tratamento de um paciente mamìfero
PT830377E (pt) Péptido-2 análogo ao glucagon e sua utilização terapêutica
MXPA01003197A (es) Suministro enterico y colonico utilizando capsulas de chpm.
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
GEP20022707B (en) Biodegrading Macromers for the Controlled Release of Biologically Active Substances
ATE435294T1 (de) Verabreichung von biologisch aktiven polypeptiden
AU1227899A (en) Osmotic medicament releasing system
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
UA41995C2 (uk) Лікарська форма азитроміцину з контрольованим вивільненням ( варіанти ), спосіб її введення, спосіб її виготовлення і спосіб лікування інфекційних захворювань ссавців з її використанням ( варіанти )
GB9323008D0 (en) Improvements relating to cancer therapy
AU5658196A (en) Method for pharmaceutical delivery
EP1203590A4 (en) CHITOSAL POWDER CONTAINING SOLID PREPARATIONS AND METHOD FOR THE PRODUCTION THEREOF
FR2730411B1 (fr) Association medicamenteuse utile pour la transfection et l'expression in vivo d'exogenes
AU2002316221A1 (en) Methods for inducing sustained immune response
BG105216A (en) Use of camptothecin derivatives , with reduced gastrointestinal toxicity
Guillevin Treatment of polyarteritis nodosa and Churg-Strauss angiitis: indications of plasma exchange. Results of three prospective trials in 162 patients. The Cooperative Study Group for the Study of Polyarteritis Nodosa
GR3019608T3 (en) Peroral administration form for peptidic medicaments, in particular insulin.
RU96119817A (ru) Способ лечения дисбактериозов кишечника
Hiller A better way to make the medicine go down: prodrugs may soon join the pharmaceutical arsenal for conditions as challenging as AIDS and cancer
RU95106139A (ru) Способ лечения туберкулеза легких
RU92016384A (ru) Фармацевтическая форма для введения лекарственного средства в ободочную кишку, способ введения лекарственного препарата и способ получения матриц для такой формы
Barkade et al. Insulin Tablet Novel Strategy for Diabetes Management
Gol'dberg et al. Acute toxicity of carminomycin administered perorally to laboratory animals
IT1254688B (it) Composizioni farmaceutiche somministrabili per via orale a rilascio mirato contenenti acido ursodesossicolico ed acido chenodesossicolico.

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee